ribociclib
novartis
['breast', ' ribo', 'natalee', 'ribociclib']
news from asco: the combination of cdk4/6 inhibitor ribociclib + endocrine therapy significantly improved invasive dfs compared with endocrine therapy alone in stage iib or iii hr+/her2- early breast cancer, according to the phase 3 natalee study. #asco23 